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tagged white blood cell scan six months later did not show any
evidence of osteomyelitis.
Conclusion: C. parapsilosis is a normal commensal of the human
skin, and is notorious for infecting hyperalimenation solutions
and catheters by forming bioﬁlms. Immunocompromised patients
and those undergoing gastrointestinal procedures are at highest
risk. In our patient, the main risk factor was habitual biting of
his thumb that led to invasive fungal disease. Among patients
not responding to conventional antibiotic therapy, early surgical
debridement for identiﬁcation of an alternate etiological agent
is crucial. C. parapsilosis is sensitive to azoles and amphotericin
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Background: Pulmonary mycosis is a budding problem world-
wide. In a developing country, it remains more so a challenge
because of increased fungal invasion in diseased lung secondary
to tuberculosis or other immunocompromised state, lack of diag-
nostic facilities and ﬁnancial constraints which pose a challenge in
proper diagnosis, follow up and treatment.
Methods & Materials: This is a prospective study of patients
with pulmonary mycosis in a tertiary care centre. 56 patients with
proven fungal culture were included. Data was collected using a
proforma which included the demographic data, clinical features,
bronchoscopic ﬁndings and fungal culture report.. The data were
entered in MS Excel. Descriptive statistics, i.e., means, standard
deviations, frequencies, and percentages, were used to describe the
study variables
Results: Mean age group of our patient was 52.36 ±14.55
years. Pulmonary mycosis occurred in the setting of pre-existing
lung disease in 64.28% of patients. Mycosis in naïve lung and
with no immunocompromised condition was seen in 17.86% while
73.21% patients had an underlying lung disease or an immuno-
compromised status. Of the total patients, 23.21% were diabetics,
5.35% were having hematological malignancies, 10.71% were hav-
ing autoimmune connective tissue disorders on steroids and 1.78%
with retroviral disease. Our data shows fungal culture isolates with
prevalence of candida albicans (69.6%), candida krusei (12.5%),
candida glaberata (10.7%), candida tropicalis (5%) and aspergillus
fumigatus (5%).
Conclusion: Pulmonary mycosis is a challenging problem in
developing countries. Though, it is found most commonly in
patients with underlying structural lung disease and immune-
compromised hosts, a high index of clinical suspicion should be
kept even in people with no obvious risk factors as primary pul-
monary mycosis incidence in naïve lung is on rise. Our study
emphasizes the role of early bronchoscopy and lavage cultures
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Background: To study the antifungal resistance proﬁles and
species distribution of Candida blood stream infection (BSI) isolates
in a tertiary-care hospital
Methods&Materials:During a 20-month period (January 2012
to August 2013) 31 immunocompromised or long-term hospital-
ized patients were detected with candidemia by blood culture. The
blood samples were inoculated in BacTec bottles and incubated
in the automated BACTEC 9240 system. Identiﬁcation of the Can-
dida clinical isolates to the species level was performed by API
ID 32C (chromogenic SDA was used for preliminary identiﬁca-
tion). Susceptibility testing to antifungal agents was performed by
Etest strips on RPMI agar according to the recently revised by CLSI
species-speciﬁc interpretive breakpoints (M27-S4).
Results: Out of 31 Candida BSI isolates 51.61%, 12.90%, 12.90%,
9.68%, 3.23%, and 9.68% were C. parapsilosis, C. albicans, C. glabrata,
C. tropicalis, C. guilliermondii, and other (C. sake, C. rugosa, C. norve-
gensis) respectively. The non-candida albicans (NCA) species were
identiﬁed in 27 (87.10%) of all the candidemia cases. C. albicans iso-
lates were susceptible to all antifungal agents tested, except for
itraconazole (50% of isolates showed intermediate resistance). One
C. tropicalis isolate was resistant to amphotericin B (AP). C. para-
psilosis isolates showed 6.25%, 38.46%, 56.25%, 12.5%, and 13.33%
resistance to AP, ﬂuconazole (FL), itraconazole (IT), caspofungin
(CS) and anidulafungin (AND), respectively. All C. parapsilosis iso-
lates were susceptible to micafungin (MYC). The resistance rate of
C. glabrata isolates was 25%, 75.0%, 25.0% and 25.0% to FL, IT, AND
and MYC respectively. One C. guilliermondii isolate was resistant
to IT, CS and AND. The overall resistance rate of NCA to AP, FL, IT,
voriconazole (VO), CS, AND and MYC was 7.41%, 34.78%, 55.56%,
3.7%, 11.11%, 15.38%, and 3.70% respectively.
Conclusion: (a) Thenon-candida albicans are themost prevalent
species causing BSI. C. parapsilosis is the most common followed by
C. glabrata, C. albicans and C. tropicalis. (b) In contrast to C. albicans
the NCA species indicate various resistance rates to antifungal
agents. The highest resistant rate was detected to itraconazole,
whereas the lowest to voriconazole and micafungin. (c) Identiﬁca-
tion to species level and susceptibility testing should be performed
for all NCA isolates
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